Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #15,551 to #15,600.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Administrative Controlled Substances Code Number (1 revision)
  2. Administrator intervention against vandalism (1 revision)
  3. Admissible decision rule (1 revision)
  4. Ado-Trastuzumab Emtansine (1 revision)
  5. Adolescent X-linked adrenoleukodystrophy (1 revision)
  6. Adonis aestivalis (1 revision)
  7. Adonis annua (1 revision)
  8. Adosterol (1 revision)
  9. Adp-ribosyltransferase 5 (1 revision)
  10. Adrenal artery (1 revision)
  11. Adrenal cortex (1 revision)
  12. Adrenal fatigue (patient information) (1 revision)
  13. Adrenal fatigue CT (1 revision)
  14. Adrenal fatigue MRI (1 revision)
  15. Adrenal fatigue case study one (1 revision)
  16. Adrenal fatigue classification (1 revision)
  17. Adrenal fatigue cost-effectiveness of therapy (1 revision)
  18. Adrenal fatigue differential diagnosis (1 revision)
  19. Adrenal fatigue epidemiology and demographics (1 revision)
  20. Adrenal fatigue future or investigational therapies (1 revision)
  21. Adrenal fatigue historical perspective (1 revision)
  22. Adrenal fatigue laboratory findings (1 revision)
  23. Adrenal fatigue medical therapy (1 revision)
  24. Adrenal fatigue natural history, complications and prognosis (1 revision)
  25. Adrenal fatigue other diagnostic studies (1 revision)
  26. Adrenal fatigue other imaging findings (1 revision)
  27. Adrenal fatigue overview (1 revision)
  28. Adrenal fatigue pathophysiology (1 revision)
  29. Adrenal fatigue physical examination (1 revision)
  30. Adrenal fatigue primary prevention (1 revision)
  31. Adrenal fatigue risk factors (1 revision)
  32. Adrenal fatigue screening (1 revision)
  33. Adrenal fatigue secondary prevention (1 revision)
  34. Adrenal fatigue surgery (1 revision)
  35. Adrenal fatigue ultrasound (1 revision)
  36. Adrenal ferredoxin (1 revision)
  37. Adrenal gland (1 revision)
  38. Adrenal hemorrhage echocardiography or ultrasound (1 revision)
  39. Adrenal tumor electrocardiogram (1 revision)
  40. Adrenarche (1 revision)
  41. Adrenocortical primary prevention (1 revision)
  42. Adrenoleukodystrophy case study one (1 revision)
  43. Adrenoleukodystrophy electroencephalogram (1 revision)
  44. Adrenosterone (1 revision)
  45. Adsorption (1 revision)
  46. Adult (1 revision)
  47. Adult Blood Lead Epidemiology and Surveillance (1 revision)
  48. Adult stem cell (1 revision)
  49. Adulterant (1 revision)
  50. Advanced Cell Technology (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)